skip to main content
Language:
Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Material Type:
Article
Add to My Research

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults

Gut, 2015-11, Vol.64 (11), p.1744-1754 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2014-307913 ;PMID: 25500202 ;CODEN: GUTTAK

Full text available

2
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-04, Vol.325 (14), p.1403 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2021.1831 ;PMID: 33625476

Digital Resources/Online E-Resources

3
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-04, Vol.325 (14), p.1414 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2021.3224 ;PMID: 33755728

Digital Resources/Online E-Resources

4
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-01, Vol.327 (2), p.138 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2021.23619 ;PMID: 35015037

Digital Resources/Online E-Resources

5
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Material Type:
Article
Add to My Research

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

Nature medicine, 2022-10, Vol.28 (10), p.2083-2091 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-02026-4 ;PMID: 36216945

Full text available

6
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
Material Type:
Article
Add to My Research

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

The Lancet (British edition), 2022-01, Vol.399 (10321), p.259-269 [Peer Reviewed Journal]

Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01640-8 ;PMID: 34895470

Full text available

7
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Material Type:
Article
Add to My Research

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

Diabetes care, 2021-06, Vol.44 (6), p.1433-1442 [Peer Reviewed Journal]

2021 by the American Diabetes Association. ;Copyright American Diabetes Association Jun 1, 2021 ;2021 by the American Diabetes Association 2021 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-2151 ;PMID: 34016612

Full text available

8
Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity
Material Type:
Article
Add to My Research

Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity

Gastroenterology (New York, N.Y. 1943), 2017-09, Vol.153 (3), p.711 [Peer Reviewed Journal]

Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved. ;EISSN: 1528-0012 ;DOI: 10.1053/j.gastro.2017.05.055 ;PMID: 28596023

Digital Resources/Online E-Resources

9
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
Material Type:
Article
Add to My Research

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

The American heart journal, 2020-11, Vol.229, p.61-69 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. The Author(s) ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2020.07.008 ;PMID: 32916609

Full text available

10
Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men
Material Type:
Article
Add to My Research

Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men

Clinical science (1979), 2016-11, Vol.130 (22), p.2073-2082 [Peer Reviewed Journal]

2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society. ;ISSN: 0143-5221 ;EISSN: 1470-8736 ;DOI: 10.1042/CS20160263 ;PMID: 27439969

Digital Resources/Online E-Resources

11
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Material Type:
Article
Add to My Research

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

The New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1808721 ;PMID: 30145941

Full text available

12
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
Material Type:
Article
Add to My Research

Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation

Diabetes (New York, N.Y.), 2016-08, Vol.65 (8), p.2282-2294 [Peer Reviewed Journal]

2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db16-0153 ;PMID: 27207552

Full text available

13
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
Material Type:
Article
Add to My Research

Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss

JAMA : the journal of the American Medical Association, 2023-11, Vol.330 (18), p.1795 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2023.19574 ;PMID: 37796527

Digital Resources/Online E-Resources

14
Natural Dietary and Herbal Products in Anti-Obesity Treatment
Material Type:
Article
Add to My Research

Natural Dietary and Herbal Products in Anti-Obesity Treatment

Molecules, 2016-10, Vol.21 (10), p.1351 [Peer Reviewed Journal]

Copyright MDPI AG 2016 ;2016 by the authors. 2016 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules21101351 ;PMID: 27727194

Full text available

15
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
Material Type:
Article
Add to My Research

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2024-01, Vol.331 (1), p.38 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2023.24945 ;PMID: 38078870

Digital Resources/Online E-Resources

16
Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies
Material Type:
Article
Add to My Research

Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies

Seminars in cancer biology, 2023-06, Vol.91, p.27 [Peer Reviewed Journal]

Copyright © 2023. Published by Elsevier Ltd. ;EISSN: 1096-3650 ;DOI: 10.1016/j.semcancer.2023.02.010 ;PMID: 36871633

Digital Resources/Online E-Resources

17
Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice
Material Type:
Article
Add to My Research

Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice

Postgraduate medicine, 2022, Vol.134 (1), p.14-19 [Peer Reviewed Journal]

2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 ;ISSN: 0032-5481 ;EISSN: 1941-9260 ;DOI: 10.1080/00325481.2021.2002616 ;PMID: 34775881

Digital Resources/Online E-Resources

18
Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial

JAMA psychiatry (Chicago, Ill.), 2017-07, Vol.74 (7), p.719 [Peer Reviewed Journal]

EISSN: 2168-6238 ;DOI: 10.1001/jamapsychiatry.2017.1220 ;PMID: 28601891

Digital Resources/Online E-Resources

19
Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-03, Vol.315 (10), p.990 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2016.1558 ;PMID: 26954408

Digital Resources/Online E-Resources

20
Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans
Material Type:
Article
Add to My Research

Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans

The American journal of clinical nutrition, 2020-08, Vol.112 (2), p.413-426 [Peer Reviewed Journal]

2020 American Society for Nutrition. ;Copyright © The Author(s) on behalf of the American Society for Nutrition 2020. 2020 ;Copyright © The Author(s) on behalf of the American Society for Nutrition 2020. ;Copyright American Society for Clinical Nutrition, Inc. Aug 2020 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.1093/ajcn/nqaa072 ;PMID: 32320006

Full text available

Personalize your results

  1. Edit

Refine Search Results

Refine My Results

Creation Date 

From To
  1. Before 2009  (30)
  2. 2009 To 2011  (120)
  3. 2012 To 2014  (110)
  4. 2015 To 2018  (181)
  5. After 2018  (260)
  6. More options open sub menu

Resource Type 

  1. Articles  (699)
  2. magazinearticle  (1)
  3. More options open sub menu

Language 

  1. English  (683)
  2. Japanese  (74)
  3. Spanish  (6)
  4. German  (5)
  5. Portuguese  (5)
  6. French  (2)
  7. Chinese  (2)
  8. Polish  (1)
  9. Hungarian  (1)
  10. Italian  (1)
  11. Norwegian  (1)
  12. More options open sub menu

Searching Remote Databases, Please Wait